Data / Research funding / Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease: 481 NIH awards ($3.7B) to 134 organizations
481 NIH awards ($3.7B) in the NIH spending category Chronic Obstructive Pulmonary Disease, to 134 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
481 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity | NIH | National Cancer Institute | 2021 to 2025 | $2,960,824,321 | August 31, 2025 | August 30, 2026 | BRISCOE, LYNN | reporter.nih.gov |
| COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $29,553,568 | August 10, 2025 | August 9, 2026 | NEWMAN, LEE S | reporter.nih.gov |
| The American Lung Association (ALA) Lung Health Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $17,159,433 | June 15, 2019 | June 30, 2026 | KALHAN, RAVI | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- COORDINATING CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $15,035,695 | November 30, 2018 | November 29, 2024 | CAI, JIANWEN | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,991,264 | February 8, 2019 | January 31, 2027 | CHAVARRO, JORGE EDUARDO | reporter.nih.gov |
| HCHS-SOL - AE FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $9,308,932 | November 30, 2018 | November 29, 2024 | KAPLAN, ROBERT | reporter.nih.gov |
| Transitions from Impaired Respiratory Health to Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $9,270,202 | August 15, 2014 | July 31, 2029 | KALHAN, RAVI | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY (STUDY OF LATINOS) FIELD CENTER - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,735,388 | November 30, 2018 | November 29, 2024 | SCHNEIDERMAN, NEIL | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- CHICAGO FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,683,049 | November 30, 2018 | November 29, 2024 | DAVIGLUS, MARTHA | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY (STUDY OF LATINOS (HCHS-SOL))FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,388,508 | November 30, 2018 | November 29, 2024 | TALAVERA, GREGORY | reporter.nih.gov |
| SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III | NIH | National Heart, Lung, and Blood Institute | 2025 | $7,234,660 | July 25, 2025 | July 24, 2026 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| Precision phenotyping of emphysema in the elderly: the MESA Lung Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,794,185 | August 2, 2004 | January 31, 2027 | BARR, R GRAHAM | reporter.nih.gov |
| (1 of 2) Genetic Epidemiology of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $6,661,979 | September 27, 2007 | July 31, 2023 | CRAPO, JAMES D | reporter.nih.gov |
| Understanding the Origins of Early COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,605,820 | May 1, 2020 | April 30, 2025 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Early Origins of Chronic Lung Disease: From Birth to Age 45 Years | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,285,181 | June 1, 2016 | June 30, 2030 | MARTINEZ, FERNANDO D | reporter.nih.gov |
| Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,833,457 | August 15, 2024 | May 31, 2031 | PUTCHA, NIRUPAMA | reporter.nih.gov |
| 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,484,720 | September 20, 2021 | August 31, 2026 | KANER, ROBERT J | reporter.nih.gov |
| 1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,371,597 | September 1, 2021 | July 31, 2027 | BHATT, SURYA P. | reporter.nih.gov |
| Neurobiology of the Bronchopulmonary System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,659,693 | March 1, 2021 | February 28, 2028 | UNDEM, BRADLEY JOEL | reporter.nih.gov |
| Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,258,583 | August 20, 2020 | June 30, 2026 | D'ARMIENTO, JEANINE M | reporter.nih.gov |
| Combined Cardiopulmonary Failure in COPD: SPIROMICS HF | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $4,223,234 | August 28, 2008 | June 30, 2025 | BARR, R GRAHAM | reporter.nih.gov |
| Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,964,079 | January 1, 2022 | December 31, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| OMEGA COPD Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,929,943 | September 20, 2021 | August 31, 2027 | HANSEL, NADIA N | reporter.nih.gov |
| Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,919,631 | February 3, 2021 | January 31, 2027 | CLEVELAND, ZACKARY I | reporter.nih.gov |
| 2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,669,568 | September 17, 2021 | August 31, 2026 | SPINO, CATHERINE A | reporter.nih.gov |
| SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression | NIH | National Heart, Lung, and Blood Institute | 2021 | $3,589,191 | September 15, 2017 | November 30, 2024 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,552,656 | April 12, 2017 | June 30, 2027 | SILVERMAN, EDWIN K | reporter.nih.gov |
| Improving shared decision making in lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,484,257 | August 15, 2021 | July 31, 2027 | HART, JOANNA LEE | reporter.nih.gov |
| 1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,465,062 | September 10, 2023 | August 31, 2029 | HANSEL, NADIA N | reporter.nih.gov |
| Patterns of Cardiopulmonary health across the life course | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,464,936 | September 1, 2021 | May 31, 2027 | KHAN, SADIYA SANA | reporter.nih.gov |
| Role of MIF and CD74 in the pathogenesis of emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,410,379 | January 1, 2021 | December 31, 2026 | BUCALA, RICHARD J | reporter.nih.gov |
| Metal Exposure and Subclinical Lung Disease in Adult E-cigarette Users | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,409,256 | February 15, 2021 | January 31, 2027 | OELSNER, ELIZABETH | reporter.nih.gov |
| Leveraging Variant-perturbed Gene Regulation to Support Precision Medicine in COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,361,465 | March 15, 2022 | February 28, 2027 | GLASS, KIMBERLY RENEE | reporter.nih.gov |
| Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,344,916 | July 1, 2015 | April 30, 2026 | HUANG, LAURENCE | reporter.nih.gov |
| Regulation of Progenitor Cell Plasticity in Lung Development and Disease-Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,331,553 | July 1, 2023 | June 30, 2030 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| Improving Participation in Pulmonary Rehabilitation through Peer-Support and Storytelling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,200,137 | September 1, 2022 | August 31, 2027 | LINDENAUER, PETER KYLE | reporter.nih.gov |
| Identifying Protein-Protein Network Interactions between COPD Susceptibility Genes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,177,138 | January 1, 2021 | December 31, 2025 | SILVERMAN, EDWIN K | reporter.nih.gov |
| Relationship of fungal translocation, inflammation, and pulmonary function in HIV | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,142,352 | July 10, 2022 | May 31, 2027 | METHE, BARBARA | reporter.nih.gov |
| Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,121,383 | August 15, 2022 | July 31, 2026 | YANIK, GREGORY A | reporter.nih.gov |
| Non-coding RNA structure change in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,120,996 | January 1, 2012 | August 31, 2027 | LAEDERACH, ALAIN T | reporter.nih.gov |
| Discovery of Gene-by-Air Pollution Interactions in Respiratory Disease using Genetically Diverse Mice with Validation in Humans | NIH | National Institute of Environmental Health Sciences | 2025 | $3,082,011 | September 19, 2025 | September 18, 2029 | KELADA, SAMIR | reporter.nih.gov |
| Pathogenic Exosomes in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,057,675 | April 1, 2023 | March 31, 2030 | BLALOCK, J EDWIN | reporter.nih.gov |
| The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,052,433 | June 1, 2020 | April 30, 2026 | PRESS, VALERIE G | reporter.nih.gov |
| Human-AI Collaborations to Improve Accuracy and Mitigate Bias in Acute Dyspnea Diagnosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,046,740 | September 20, 2021 | August 31, 2025 | SJODING, MICHAEL WILLIAM | reporter.nih.gov |
| Hepatocyte Growth Factor Signaling and Airspace Maintenance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,997,638 | September 1, 2021 | May 31, 2026 | NEPTUNE, ENID R | reporter.nih.gov |
| A Novel Exosomal Inflammatory Pathway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,996,900 | January 18, 2017 | March 31, 2023 | BLALOCK, J EDWIN | reporter.nih.gov |
| Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,995,164 | April 21, 2021 | July 31, 2025 | COONEY, CHRISTOPHER GERARD | reporter.nih.gov |
| The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,964,430 | May 8, 2021 | April 30, 2026 | DRUMMOND, MICHAEL BRADLEY | reporter.nih.gov |
| Rehabilitation in Safety-Net Environments (RISE) for COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,953,161 | February 1, 2022 | January 31, 2027 | THAKUR, NEETA | reporter.nih.gov |
| Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,937,551 | April 15, 2022 | March 31, 2027 | WASHKO, GEORGE R | reporter.nih.gov |
| DeepCOPD: Development and Implementation of Deep Learning to Predict and Prevent COPD Health Care Encounters | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,927,246 | December 20, 2021 | November 30, 2026 | BROWN, JEREMIAH R | reporter.nih.gov |
| The Role of HuR in HIV related COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,901,310 | September 1, 2022 | June 30, 2027 | FORONJY, ROBERT F | reporter.nih.gov |
| Deep Functional Phenotyping of the ALA Lung Health Cohort | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,888,675 | August 15, 2022 | July 31, 2027 | IRVIN, CHARLES G | reporter.nih.gov |
| SPIROMICS GIC Support | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,798,405 | August 15, 2018 | July 31, 2024 | COUPER, DAVID J | reporter.nih.gov |
| Drug abuse and HIV-associated pulmonary vascular injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,784,947 | February 1, 2021 | December 31, 2025 | DHILLON, NAVNEET KAUR | reporter.nih.gov |
| Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,784,669 | August 15, 2021 | July 31, 2025 | MANICHAIKUL, ANI WANG | reporter.nih.gov |
| S-glutathionylation chemistry in fibrotic lung remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,783,548 | January 1, 2017 | December 31, 2023 | JANSSEN-HEININGER, YVONNE M. W. | reporter.nih.gov |
| Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,768,708 | September 12, 2014 | June 30, 2027 | CRANE, HEIDI M. | reporter.nih.gov |
| Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTL | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,744,141 | September 1, 2014 | May 31, 2026 | CASTALDI, PETER | reporter.nih.gov |
| Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI | NIH | National Cancer Institute | 2021 to 2025 | $2,741,941 | September 17, 2021 | August 31, 2027 | RUSET, IULIAN CONSTANTIN | reporter.nih.gov |
| COPD cachexia: deciphering the impact of antioxidants, iron and mitochondrial function using 'omics approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,723,054 | June 10, 2021 | May 31, 2025 | MCDONALD DONNELLY, MERRY-LYNN NOELLE | reporter.nih.gov |
| Robust Clinical Translation of CT Imaging Biomarker in COPD for EBV Patient Selection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,711,888 | April 1, 2021 | March 31, 2025 | MCNITT-GRAY, MICHAEL F | reporter.nih.gov |
| Metabolic Control of Stemness in lung epithelial progenitors by FAM13A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,676,003 | April 1, 2015 | November 30, 2025 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,672,766 | May 1, 2011 | June 30, 2029 | BAYLISS, DOUGLAS A. | reporter.nih.gov |
| B cell-adaptive Immune Profile in Emphysema-predominant COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,670,764 | September 1, 2020 | August 31, 2025 | POLVERINO, FRANCESCA | reporter.nih.gov |
| The role of epigenetics in the adverse effects of social environmental stressors on COPD outcomes | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,670,723 | April 13, 2021 | January 31, 2027 | LADD-ACOSTA, CHRISTINE | reporter.nih.gov |
| Understanding airway mucus dysfunction in population-based studies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,669,952 | August 15, 2022 | July 31, 2027 | DIAZ, ALEJANDRO | reporter.nih.gov |
| Ceramide-Induced Destruction in Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,661,589 | July 1, 2006 | April 30, 2025 | PETRACHE, IRINA | reporter.nih.gov |
| Imaging the functional response of the lung to bronchoscopic lung volume reduction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,659,733 | August 10, 2022 | July 31, 2027 | RIZI, RAHIM R | reporter.nih.gov |
| Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy | NIH | National Cancer Institute | 2021 to 2025 | $2,631,104 | June 1, 2020 | February 28, 2027 | BRAITHWAITE, DEJANA K | reporter.nih.gov |
| Defining mechanisms of CC16 on epithelial-driven host responses to pathogens | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,607,906 | September 1, 2019 | June 30, 2028 | LEDFORD, JULIE GUNNELLS | reporter.nih.gov |
| Imaging and multi-omics analyses to identify molecular subtypes of distinct emphysema patterns | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,605,661 | September 1, 2023 | July 31, 2028 | EL BOUEIZ, ADEL | reporter.nih.gov |
| Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,525,727 | March 20, 2020 | February 28, 2026 | WILLIAMS, MARC S. | reporter.nih.gov |
| Gene Therapy for Alpha 1-Antitrypsin Deficiency | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,505,334 | May 15, 2024 | April 30, 2028 | CRYSTAL, RONALD G | reporter.nih.gov |
| Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,481,198 | June 1, 2023 | May 31, 2027 | HERSH, CRAIG P | reporter.nih.gov |
| Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,456,454 | August 9, 2020 | May 31, 2025 | DIAZ, ALEJANDRO | reporter.nih.gov |
| Risk Stratification for COPD Exacerbations with CT Analysis and Multidimensional Trajectory Subtyping | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,448,553 | April 15, 2023 | February 29, 2028 | ROSS, JAMES | reporter.nih.gov |
| Hyperpolarized 129Xe MRI to identify structural determinants of low lung function and respiratory symptoms in young adults from the Lung Health Cohort | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,436,083 | June 16, 2023 | March 31, 2028 | NIEDBALSKI, PETER JAMES | reporter.nih.gov |
| Airway Tree Subtyping on Large Cohorts of CT Images for COPD Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,406,566 | July 1, 2021 | June 30, 2026 | LAINE, ANDREW FRANCIS | reporter.nih.gov |
| Leveraging the dyad: mechanisms of an intervention for psychological distress in chronic lung disease | NIH | National Institute of Nursing Research | 2023 to 2025 | $2,398,789 | September 22, 2023 | June 30, 2027 | HART, JOANNA LEE | reporter.nih.gov |
| Ancillary SOURCE Study: Characterization of Small Airway Basal Cell Biology in Early COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,390,610 | June 1, 2023 | May 31, 2027 | CRYSTAL, RONALD G | reporter.nih.gov |
| Trajectories of Regional Cardiopulmonary Structure and Function in A Longitudinal Cohort of Extremely Preterm Infants | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,365,315 | May 2, 2023 | February 29, 2028 | HYSINGER, ERIK BRADFORD | reporter.nih.gov |
| (2 of 2) Genetic Epidemiology of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,362,897 | September 27, 2007 | July 31, 2023 | SILVERMAN, EDWIN K | reporter.nih.gov |
| Metabolic Landscape of the Aging Lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,355,987 | May 15, 2020 | April 30, 2026 | BARNES, JARROD W. | reporter.nih.gov |
| Developmental Origins of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,338,162 | April 5, 2021 | March 31, 2025 | BENJAMIN, JOHN | reporter.nih.gov |
| Fungal Translocation in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,331,334 | April 15, 2022 | March 31, 2026 | BON, JESSICA | reporter.nih.gov |
| The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,318,205 | September 1, 2023 | July 31, 2028 | MALHOTRA, ATUL | reporter.nih.gov |
| Uncovering the genetically-driven differential susceptibility to chronic obstructive pulmonary disease and pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,300,073 | December 15, 2022 | November 30, 2027 | CHO, MICHAEL H. | reporter.nih.gov |
| A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,267,449 | August 15, 2025 | July 31, 2027 | DONN, KARL H | reporter.nih.gov |
| Multi-omic networks associated with COPD progression in TOPMed Cohorts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,263,919 | April 5, 2020 | March 31, 2026 | KECHRIS-MAYS, KATHERINA | reporter.nih.gov |
| A Randomized Controlled Trial of Home Air Purification for Eosinophilic COPD | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,257,861 | May 15, 2020 | September 30, 2024 | RICE, MARY B | reporter.nih.gov |
| Epigenetic mechanisms of inflammatory memory propagation in human airway epithelia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,249,254 | May 5, 2022 | January 31, 2027 | PEZZULO, ALEJANDRO ANTONIO | reporter.nih.gov |
| Metabolic regulation of hypercapnic chronic obstructive pulmonary disease (COPD)-driven skeletal muscle dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,225,395 | December 15, 2021 | November 30, 2026 | JAITOVICH, ADOLFO ARIEL | reporter.nih.gov |
| Deep Learning and Subtyping of Post-COVID-19 Lung Progression Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,221,683 | June 1, 2023 | February 29, 2028 | LIN, CHING-LONG | reporter.nih.gov |
| Sexual dimorphism in susceptibility to emphysematous tissue injury | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,217,911 | June 1, 2023 | May 31, 2027 | SHIM, YUN MICHAEL | reporter.nih.gov |
| Dysregulated Immunometabolism and Premature Senescence in Corticosteroid-Refractory Severe Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,209,066 | February 1, 2023 | January 31, 2030 | RAY, ANURADHA | reporter.nih.gov |
| Accuracy and Precision in CT Quantification of COPD Through Virtual Imaging Trials | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,198,800 | July 1, 2021 | June 30, 2027 | ABADI, EHSAN | reporter.nih.gov |
| Non-Classical Cytokine Secretion in Chronic Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,192,673 | July 1, 2020 | June 30, 2026 | ALEXANDER-BRETT, JENNIFER | reporter.nih.gov |
| Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,189,214 | December 15, 2020 | November 30, 2025 | ROWE, STEVEN MARK | reporter.nih.gov |
| Role of FABP5 in COPD Exacerbations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,179,399 | June 15, 2019 | June 30, 2028 | GALLY, FABIENNE | reporter.nih.gov |
| Regulatory roles of peptidylarginine deimination in elastogenisis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,172,338 | April 15, 2022 | March 31, 2026 | HO, I-CHENG | reporter.nih.gov |
| Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,124,759 | March 10, 2022 | February 28, 2027 | QU, ZHAOXIA | reporter.nih.gov |
| Lymphatic Dysfunction in the Pathogenesis of COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,118,673 | April 1, 2023 | January 31, 2028 | REED, HASINA OUTTZ | reporter.nih.gov |
| COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS R01HL157879 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,111,042 | August 24, 2022 | June 30, 2026 | BENOS, PANAGIOTIS V | reporter.nih.gov |
| Resetting the Clock in HIV associated COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,102,860 | July 27, 2022 | June 30, 2027 | UNWALLA, HOSHANG JEHANGIR | reporter.nih.gov |
| Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,100,530 | August 15, 2023 | July 31, 2028 | VANDIVIER, RICHARD W | reporter.nih.gov |
| Structural Determinants of Disease Progression in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,086,195 | April 5, 2020 | March 31, 2026 | BHATT, SURYA P. | reporter.nih.gov |
| Prognostic Markers of Emphysema Progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,075,083 | March 15, 2020 | February 28, 2026 | SAN JOSE ESTEPAR, RAUL | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) BRONX FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,063,192 | November 30, 2024 | November 29, 2025 | reporter.nih.gov | |
| Loss of progenitor function accelerates lung aging | NIH | National Institute on Aging | 2023 to 2025 | $2,062,620 | June 15, 2023 | February 29, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,059,255 | August 1, 2023 | April 30, 2028 | KLIMENT, CORRINE R | reporter.nih.gov |
| Prediction of COPD Progression by PRM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,058,675 | March 15, 2020 | February 28, 2025 | HAN, MEILAN K | reporter.nih.gov |
| A New Small-Molecule Kinase Inhibitor for Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,038,199 | August 7, 2019 | June 30, 2027 | BROSCHAT, KAY O | reporter.nih.gov |
| Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,034,476 | February 1, 2022 | January 31, 2026 | MCKEON, FRANK D. | reporter.nih.gov |
| NAEOTOM Alpha Photon-Counting CT Scanner | NIH | Office of the Director, National Institutes of Health | 2024 | $2,000,000 | August 15, 2024 | November 14, 2025 | HOFFMAN, ERIC ALFRED | reporter.nih.gov |
| A Disease-Modifying Protein Therapeutic for the Treatment of COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,999,973 | September 15, 2019 | April 30, 2025 | PRINCE, CHRISTOPHER LUCAS | reporter.nih.gov |
| An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,995,107 | March 1, 2023 | February 28, 2027 | NICOLA, TEODORA | reporter.nih.gov |
| The CAPTURE Study: Validating a unique COPD screening tool in primary care | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,983,602 | September 1, 2017 | June 30, 2024 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Integrative Characterization on the function of COPD GWAS gene, HHIP | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,966,527 | April 5, 2020 | March 31, 2025 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| 2/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,960,949 | September 10, 2023 | August 31, 2029 | EHRHARDT, STEPHAN | reporter.nih.gov |
| Aberrant Micro-managing of the Airway Epithelial Transcriptome in HIV-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,926,393 | April 1, 2023 | January 31, 2027 | UNWALLA, HOSHANG JEHANGIR | reporter.nih.gov |
| Endobronchial Supervalve for the Treatment of Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,919,606 | December 1, 2020 | November 30, 2024 | GELFAND, MARK | reporter.nih.gov |
| Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,919,203 | July 6, 2020 | June 30, 2025 | NEPTUNE, ENID R | reporter.nih.gov |
| Mechanisms Controlling Expansion and Lineage Specification of Airway Progenitors in Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,919,136 | January 1, 2017 | June 30, 2023 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| Quercetin prevent airway epithelial remodeling and promote lung health in OPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,898,463 | July 1, 2021 | June 30, 2025 | SAJJAN, UMADEVI SIVANAPPA | reporter.nih.gov |
| Role of FBXO24 mediated ubiquitination of FoxP1 protein in the pathogenesis and treatment of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,874,669 | July 15, 2020 | June 30, 2025 | CHANDRA, DIVAY | reporter.nih.gov |
| Epigenetic Regulation of the Maturation and Function of Lung Epithelium by the SWI/SNF Proteins ARID1A and ARID1B. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,858,845 | May 20, 2021 | April 30, 2026 | ZACHARIAS, WILLIAM JOHN | reporter.nih.gov |
| Respiratory Oxygen Adherence Monitor for COPD Patients | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,853,684 | September 1, 2019 | July 31, 2025 | KREPKOVICH, EILEEN T. | reporter.nih.gov |
| The Home Environment and Re-hospitalization in COPD study (HEAR COPD) | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,852,483 | September 15, 2019 | May 31, 2026 | PUTCHA, NIRUPAMA | reporter.nih.gov |
| Translational Program in CFTR-Related Airway Diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,835,932 | January 15, 2017 | September 30, 2022 | ROWE, STEVEN MARK | reporter.nih.gov |
| Role of E-cadherin in modulating airway epithelial function and parenchymal remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,834,908 | April 5, 2020 | March 31, 2024 | SIDHAYE, VENKATARAMANA K | reporter.nih.gov |
| Siderophore based molecular imaging of pulmonary infections | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,833,928 | July 1, 2023 | June 30, 2028 | KOTAGIRI, NALINIKANTH | reporter.nih.gov |
| Circadian Signatures in Chronic Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,833,797 | August 1, 2020 | May 31, 2025 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
| Mechanisms of DNA damage induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,827,951 | July 15, 2014 | May 31, 2025 | ARMANIOS, MARY Y | reporter.nih.gov |
| 1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 | $1,826,564 | September 10, 2023 | August 31, 2024 | HANSEL, NADIA N | reporter.nih.gov |
| Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,814,231 | November 11, 2022 | May 31, 2026 | ZAHID, MALIHA | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) CHICAGO FIELD CENTER - TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,789,061 | November 30, 2024 | November 29, 2025 | DAVIGLUS, MARTHA L | reporter.nih.gov |
| Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,770,374 | May 1, 2019 | April 30, 2024 | SILVERMAN, EDWIN K | reporter.nih.gov |
| Clinical implications and Proteomics of Bronchiectasis Progression in Smokers | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,760,335 | May 15, 2024 | February 29, 2028 | DIAZ, ALEJANDRO | reporter.nih.gov |
| Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,759,301 | March 15, 2024 | February 29, 2028 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| Genetic variants that affect the airway epithelium to drive obstructive lung disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,748,401 | April 1, 2024 | March 31, 2028 | TESFAIGZI, YOHANNES | reporter.nih.gov |
| Oxidant Signaling in Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,746,731 | July 10, 2023 | June 30, 2027 | RESTA, THOMAS C | reporter.nih.gov |
| Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,730,175 | September 1, 2019 | July 31, 2025 | WOLF, ALEXANDER KEITH | reporter.nih.gov |
| SCGE Disease Models Studies Supplement: Evaluation of prime editing for the amelioration of alpha-1-antitrypsin deficiency in murine and porcine models. | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $1,724,497 | September 20, 2018 | July 31, 2024 | CARLSON, DANIEL FRED | reporter.nih.gov |
| Interactive Training Tool Providing Technique Feedback for COPD Medication Delivery | NIH | National Institute on Aging | 2021 to 2023 | $1,703,425 | March 1, 2021 | February 28, 2025 | LICHTER, PATRICK | reporter.nih.gov |
| Portable Noninvasive Positive Airway Device for COPD Patient Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,667,587 | August 15, 2020 | July 31, 2025 | KNUESEL, ROBERT J | reporter.nih.gov |
| Mindful Steps: A Web-Based Mind-Body Exercise Intervention to Promote Physical Activity in Chronic Cardiopulmonary Disease | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $1,666,915 | September 5, 2023 | June 30, 2028 | YEH, GLORIA Y | reporter.nih.gov |
| Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,656,289 | June 1, 2021 | May 31, 2023 | VINE, DAVID | reporter.nih.gov |
| Harnessing Inflammatory Macrophages to Thwart Lung Disease Caused by Chronic Ozone Exposure | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,647,275 | February 15, 2022 | November 30, 2026 | LASKIN, DEBRA L | reporter.nih.gov |
| DNA Repair Capacity Assays for Lung Disease Risk Assessment | NIH | National Cancer Institute | 2021 to 2022 | $1,638,124 | September 1, 2018 | August 31, 2024 | BELINSKY, STEVEN A | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) MIAMI FIELD CENTER - TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,631,843 | November 30, 2024 | November 29, 2025 | PENEDO, FRANK | reporter.nih.gov |
| Imaging of Hematologic and Oncologic Disorders | NIH | National Cancer Institute | 2021 to 2022 | $1,625,586 | May 1, 2016 | April 30, 2024 | ROSS, BRIAN D. | reporter.nih.gov |
| Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,595,582 | September 15, 2019 | July 31, 2025 | HUANG, LAURENCE | reporter.nih.gov |
| EMAI-COPD: An Ethical Multimodal AI Model for Preventive, Diagnostic, and Therapeutic Interventions in Chronic Obstructive Pulmonary Disease | NIH | Office of the Director, National Institutes of Health | 2025 | $1,592,119 | September 8, 2025 | September 7, 2026 | BANAEI-KASHANI, FARNOUSH | reporter.nih.gov |
| Mapping Airway Epithelial Cell-Immune Cell Interactions in Lung Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,579,374 | September 1, 2024 | August 31, 2029 | MEDOFF, BENJAMIN DAVID | reporter.nih.gov |
| Nutritional Omics of Pulmonary Function Decline | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,578,591 | September 23, 2019 | July 31, 2024 | HANCOCK, DANA B | reporter.nih.gov |
| Evaluating the Impact of Non-COPD Medications on COPD Management | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,574,520 | September 17, 2024 | June 30, 2029 | BYKOV, KATSIARYNA | reporter.nih.gov |
| COPD GWAS Functional Variant Identification in Airway Epithelial Cells using Deep Learning Splicing Models | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,570,184 | August 1, 2024 | May 31, 2028 | CASTALDI, PETER | reporter.nih.gov |
| The Penn LungMAP 3 team: Defining chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,569,484 | September 1, 2024 | August 31, 2029 | MORRISEY, EDWARD E | reporter.nih.gov |
| Dynamic imaging of lung function in free-breathing subjects | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,560,271 | September 15, 2024 | June 30, 2029 | RIZI, RAHIM R | reporter.nih.gov |
| Genome Evolution During Bacterial Persistence in the Human Airways in COPD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,545,389 | September 30, 1983 | June 30, 2025 | MURPHY, TIMOTHY F | reporter.nih.gov |
| 1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD) | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,537,067 | September 1, 2021 | July 31, 2022 | BHATT, SURYA P. | reporter.nih.gov |
| A multi-scale computational model of the extracellular matrix of the lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,533,586 | June 1, 2018 | May 31, 2024 | SUKI, BELA | reporter.nih.gov |
| Pulmonary Specialist-Health Coach Consult (PuSHCon) model to improve access to specialist consultation and receipt of recommended evidence-based care for vulnerable patients with COPD and asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,516,955 | September 1, 2019 | July 31, 2025 | WILLARD-GRACE, RACHEL | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) SAN DIEGO FIELD CENTER - TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,508,747 | November 30, 2024 | November 29, 2025 | GALLO, LINDA C | reporter.nih.gov |
| CC16 in childhood and resilience to early airflow limitation in adult life | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,495,333 | September 25, 2017 | March 31, 2030 | GUERRA, STEFANO | reporter.nih.gov |
| Protective effects of metformin against cigarette smoke-induced lung pathologies via regulation of fatty acids metabolism | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,492,860 | August 1, 2024 | July 31, 2028 | POLVERINO, FRANCESCA | reporter.nih.gov |
| Cross-Disease Multi-Modality Mapping of the Human Lung | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,491,262 | September 1, 2024 | August 31, 2029 | SUN, XIN | reporter.nih.gov |
| A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,485,000 | May 1, 2022 | April 30, 2027 | GENSCHMER, KRISTOPHER R. | reporter.nih.gov |
| Bilateral Acoustic Sensing and Automated Breathing Segmentation for Remote Monitoring of Patients with COPD: A Longitudinal Study | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,480,353 | May 19, 2025 | August 31, 2025 | EMOKPAE, LLOYD E | reporter.nih.gov |
| Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration | NIH | National Eye Institute | 2021 to 2024 | $1,467,451 | January 1, 2020 | December 31, 2025 | ROHRER, BAERBEL | reporter.nih.gov |
| Impact of Macrophage Carbon Load and Epigenetic Aging on Lung Function Decline and Mortality | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,459,770 | March 14, 2024 | February 28, 2029 | LENG, SHUGUANG | reporter.nih.gov |
| Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,458,595 | August 1, 2014 | April 30, 2025 | BARR, R GRAHAM | reporter.nih.gov |
| CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,458,211 | July 1, 2018 | April 30, 2025 | SAHA, PUNAM K. | reporter.nih.gov |
| Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,438,354 | January 15, 2024 | December 31, 2027 | SERBAN, KARINA | reporter.nih.gov |
| Identifying Subtypes of COPD Using Metabolomic and Genomic Approaches | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,434,784 | May 10, 2024 | April 30, 2028 | CHO, MICHAEL H. | reporter.nih.gov |
| Interpretable graphical models for large multi-modal COPD data (R01HL159805) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,434,389 | July 25, 2021 | June 30, 2026 | BENOS, PANAGIOTIS V | reporter.nih.gov |
| 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,432,888 | September 20, 2021 | August 31, 2022 | KANER, ROBERT J | reporter.nih.gov |
| Matrikines and COPD-PH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,416,723 | September 15, 2019 | August 31, 2025 | WELLS, JAMES MICHAEL | reporter.nih.gov |
| Lung-on-a-Chip Disease Models for Efficacy Testing | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,413,750 | September 1, 2017 | October 31, 2022 | INGBER, DONALD E | reporter.nih.gov |
| Comprehensive Patient-centered Home-based care coaching for COPD self-management | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,412,237 | February 1, 2024 | January 31, 2029 | FEDERMAN, ALEX D | reporter.nih.gov |
| Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,412,018 | December 2, 2021 | December 31, 2025 | ORTEGA, VICTOR E. | reporter.nih.gov |
| Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,348,952 | September 20, 2018 | February 15, 2023 | FINKELSTEIN, JOSEPH E | reporter.nih.gov |
| Defining the Role of Viral Infections and Autoantibodies in Chronic Obstructive Pulmonary Disease Progression | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,344,350 | July 16, 2024 | April 30, 2028 | RUCZINSKI, INGO | reporter.nih.gov |
| REACH-SPIROMICS: Research on Environmental Aeroallergens, COPD, and Health in SPIROMICS | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,340,292 | August 1, 2025 | May 31, 2029 | KAUFMAN, JOEL DANIEL | reporter.nih.gov |
| Integrative, age-related changes in genome and epigenome in human lung in relation to smoking | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,327,731 | January 1, 2019 | December 31, 2023 | SPIVACK, SIMON D | reporter.nih.gov |
| Multiscale Modeling of Lung Disease-Influenced Aerosol Dosimetry | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,300,000 | September 1, 2018 | June 30, 2024 | DARQUENNE, CHANTAL | reporter.nih.gov |
| Leveraging Quantitative Imaging from Lung Cancer Screening to Create Tools to Confront COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,299,221 | September 1, 2024 | July 31, 2028 | HAN, MEILAN K | reporter.nih.gov |
| Advancing telemedicine in pulmonology: acoustic-waveform respiratory evaluation (AWARE) via sensing and machine learning on smartphones | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,290,522 | May 20, 2024 | April 30, 2029 | FORNO, ERICK | reporter.nih.gov |
| The Human Distal Airway Aging Project | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,276,622 | January 1, 2019 | December 31, 2023 | SHAYKHIEV, RENAT | reporter.nih.gov |
| Home Based Rehabilitation for COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,275,509 | March 5, 2018 | January 31, 2024 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD) | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,269,855 | September 15, 2018 | May 31, 2025 | HANSEL, NADIA N | reporter.nih.gov |
| HIV-Associated Lung Disease: The Role of Nasal Mucosal Immunity and Microbiome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,268,710 | August 15, 2024 | June 30, 2029 | DRUMMOND, MICHAEL BRADLEY | reporter.nih.gov |
| Determinants of 5 Year Progression of Muscle Dysfunction and Inactivity in COPDGene Participants. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,246,331 | February 1, 2020 | January 31, 2025 | ROSSITER, HARRY B | reporter.nih.gov |
| Predicting Sleep, Smoking and Lung Health Disparities in at-risk Black African American Adults | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,225,354 | April 1, 2018 | November 30, 2023 | SATTI, ADITI GHATGE | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) COORDINATING CENTER - TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,216,362 | November 30, 2024 | November 29, 2025 | CAI, JIANWEN | reporter.nih.gov |
| Role of TACC2 in smoking-induced COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,181,575 | February 15, 2020 | December 31, 2024 | NYUNOYA, TORU | reporter.nih.gov |
| Early life exposures and chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | April 1, 2020 | February 28, 2025 | ROMAN, JESSE | reporter.nih.gov |
| The role of mucus and pulmonary surface interactions in lung defense | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,166,250 | July 3, 2015 | June 30, 2025 | BUTTON, BRIAN M | reporter.nih.gov |
| Integrating Multi-Modal Data and Biomechanics in COPD: Toward Robust and Interpretable Biomarkers for Disease Subtyping and Progression | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,163,790 | May 1, 2018 | February 28, 2030 | BATMANGHELICH, KAYHAN | reporter.nih.gov |
| Feelix @ Home: Testing and optimization of a smart stethoscope for home use to monitor changes in lung status of individuals with chronic conditions | NIH | National Heart, Lung, and Blood Institute | 2022 | $1,148,290 | August 1, 2020 | July 31, 2023 | BUSCH-VISHNIAC, ILENE JOY | reporter.nih.gov |
| Novel Vector Platform for Gene Therapy | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $1,146,366 | July 1, 2019 | March 31, 2024 | CURIEL, DAVID TERRY | reporter.nih.gov |
| Impact of quercetin on inflammatory and oxidative stress markers in COPD | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $1,133,111 | September 9, 2022 | May 31, 2026 | SAJJAN, UMADEVI SIVANAPPA | reporter.nih.gov |
| 2/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,125,602 | September 1, 2021 | July 31, 2027 | ABAN, INMACULADA | reporter.nih.gov |
| Tau Mediates Microtubule and Mitochondrial Dynamics to Control Cellular Organization and Alveolar Epithelial Repair | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,124,966 | August 10, 2024 | May 31, 2029 | TATA, ALEKSANDRA | reporter.nih.gov |
| Multi-omic Characterization of COPD in Females | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,124,116 | August 1, 2024 | July 31, 2028 | LIU, DAJIANG | reporter.nih.gov |
| Molecular Mechanisms Regulated by FOXM1 in Chronic Lung Remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,119,330 | June 1, 2020 | March 3, 2023 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| Harnessing multi-omics to identify host-microbiome interactions driving HIV-associated chronic obstructive pulmonary disease in low and middle income countries. | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,081,912 | September 25, 2024 | July 31, 2029 | PATEL, SWETA MAHESH | reporter.nih.gov |
| A home-based intervention to promote mindful breathing awareness through pursed-lip breathing training for COPD patients | NIH | National Center for Complementary & Integrative Health | 2021 to 2022 | $1,059,639 | August 1, 2017 | April 30, 2024 | KRAMER, KEVIN M. | reporter.nih.gov |
| Chymotrypsin-like Elastase 1 in Lung Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,058,322 | April 15, 2018 | March 31, 2024 | ZINGARELLI, BASILIA | reporter.nih.gov |
| Exhaled small RNA biomarkers to detect and monitor airway disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,048,432 | January 1, 2021 | December 31, 2023 | SPIVACK, SIMON D | reporter.nih.gov |
| Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers | NIH | National Cancer Institute | 2022 to 2024 | $1,035,518 | July 11, 2022 | June 30, 2026 | SIEREN, JESSICA C | reporter.nih.gov |
| Non-canonical WNT signaling in emphysema and lung regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,027,860 | February 1, 2019 | April 30, 2025 | KOENIGSHOFF, MELANIE | reporter.nih.gov |
| Portable Low-Cost Pulmonary Forced Oscillation Technique Device | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $999,887 | September 1, 2024 | August 31, 2026 | LICHTER, PATRICK A | reporter.nih.gov |
| Environmental Cadmium and COPD | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $994,213 | September 21, 2018 | June 30, 2024 | ANTONY, VEENA B. | reporter.nih.gov |
| Allergen Exposure Reduction as a Disease-Modifying Strategy in Allergen-Sensitized Children with Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $990,900 | September 1, 2021 | August 31, 2026 | GRANT, TORIE | reporter.nih.gov |
| Platelet Activation Pathways and Respiratory Morbidity in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $986,363 | February 20, 2021 | January 31, 2027 | FAWZY, ASHRAF | reporter.nih.gov |
| Aging Well with COPD through Geriatrics-Palliative Care | NIH | National Institute on Aging | 2021 to 2024 | $971,420 | September 15, 2020 | May 31, 2025 | IYER, ANAND SATHYAN | reporter.nih.gov |
| Integrative Informatics Approach to Predict Readmissions and Improve Outcomes in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $962,055 | May 1, 2021 | March 31, 2026 | JACOBS, DAVID | reporter.nih.gov |
| Identification of immune cell-cell communication networks and inflammatory pulmonary microenvironments associated with the progression of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $959,532 | March 15, 2019 | February 28, 2025 | ARNOLD, KELLY | reporter.nih.gov |
| Targeted vaccines against pulmonary NTM infections in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $950,092 | December 20, 2024 | November 30, 2029 | COLER, RHEA N | reporter.nih.gov |
| An Early Imaging Marker of Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $949,062 | May 28, 2019 | April 30, 2024 | GALBAN, CRAIG J | reporter.nih.gov |
| Integrative 'Omics of Transcriptome Complexity in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $944,308 | April 1, 2021 | November 30, 2026 | SAFERALI, AABIDA | reporter.nih.gov |
| Mechanisms of defective mitophagy and cellular senescence in HIV associated COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $938,582 | July 15, 2019 | June 30, 2025 | UNWALLA, HOSHANG JEHANGIR | reporter.nih.gov |
| Biomarker of Lung Disease in African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 | $934,082 | August 15, 2018 | May 31, 2023 | BOWLER, RUSSELL PAUL | reporter.nih.gov |
| Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $933,377 | July 15, 2020 | June 30, 2022 | D'ARMIENTO, JEANINE M | reporter.nih.gov |
| A CRISP(e)R approach to alleviating HIV-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $932,356 | September 1, 2024 | May 31, 2028 | CHINNAPAIYAN, SRINIVASAN | reporter.nih.gov |
| Role of hypercapnia on the lung airways | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $912,973 | April 1, 2019 | February 28, 2023 | SZNAJDER, JACOB I | reporter.nih.gov |
| The influence of air pollution on lung health among people living with HIV. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $903,011 | September 5, 2020 | August 31, 2025 | NORTH, CRYSTAL | reporter.nih.gov |
| AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease | NIH | National Center for Advancing Translational Sciences | 2021 | $896,654 | April 9, 2018 | August 31, 2023 | DRANSFIELD, MARK T | reporter.nih.gov |
| Multi-component INTERLUNG intervention to protect lung health in Nepal | NIH | National Institute of Environmental Health Sciences | 2025 | $893,525 | March 19, 2025 | February 28, 2030 | CHECKLEY, WILLIAM | reporter.nih.gov |
| Semiparametric Regression Analysis of Interval-Censored Data in Current Cohort Studies | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $815,807 | March 10, 2024 | February 29, 2028 | ZENG, DONGLIN | reporter.nih.gov |
| Clinical CT Imaging for Screening and Subtyping of Pulmonary Hypertension in COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $812,189 | May 1, 2025 | February 28, 2029 | RAHAGHI, FARBOD NICHOLAS | reporter.nih.gov |
| Deciphering respiratory disease mechanisms through integration of genomic and functional data across massive global biobanks | NIH | National Heart, Lung, and Blood Institute | 2025 | $805,921 | September 10, 2025 | June 30, 2030 | MARTIN, ALICIA | reporter.nih.gov |
| MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $803,002 | September 1, 2018 | August 31, 2023 | CORRY, DAVID B | reporter.nih.gov |
| Interrogating the pathogenesis of COPD using metabolomics and genomics data | NIH | National Heart, Lung, and Blood Institute | 2025 | $800,679 | September 15, 2025 | May 31, 2029 | MANICHAIKUL, ANI WANG | reporter.nih.gov |
| SMILE (Sickle Cell Disease Microbiologic and Immunologic Links to Health) | NIH | National Heart, Lung, and Blood Institute | 2025 | $794,661 | September 19, 2025 | June 30, 2030 | KOPP, BENJAMIN T | reporter.nih.gov |
| Air Pollution's Impact on Lung Aging in HIV | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $793,396 | July 1, 2022 | June 30, 2027 | RAJU, SARATH | reporter.nih.gov |
| Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $793,025 | June 1, 2022 | May 31, 2027 | BALASUBRAMANIAN, APARNA | reporter.nih.gov |
| Prenatal pulmonary cell gene editing to cure monogenic lung diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $792,162 | July 1, 2020 | July 31, 2023 | PERANTEAU, WILLIAM H. | reporter.nih.gov |
| Decreasing Disparity in Lung Disease: Pulmonary Rehabilitation for Rural Patients with COPD | NIH | National Institute of Nursing Research | 2024 | $786,734 | September 20, 2024 | May 31, 2029 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Hyperpolarized Xenon-129 MRI: a new multi-dimensional biomarker to determine pulmonary physiologic responses to COPD therapeutics | NIH | National Heart, Lung, and Blood Institute | 2021 | $786,595 | January 15, 2017 | December 31, 2023 | SHIM, YUN MICHAEL | reporter.nih.gov |
| Increasing Adherence to Pulmonary Rehabilitation after COPD-related Hospitalizations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $785,106 | September 20, 2018 | September 25, 2024 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Pulmonary Rehabilitation for Rural Patients with COPD | NIH | National Institute of Nursing Research | 2025 | $784,990 | September 20, 2024 | June 30, 2030 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Role of Cofilin-1 in Mitochondrial Quality Control Influencing Mechanisms of Airway Epithelial Dysfunction in Chronic Bronchitis | NIH | National Heart, Lung, and Blood Institute | 2025 | $762,867 | May 1, 2025 | February 28, 2029 | SIDHAYE, VENKATARAMANA K | reporter.nih.gov |
| Developing Lithium as a Disease-Modifying Therapy for Emphysema Using a Precision Medicine Approach | NIH | National Heart, Lung, and Blood Institute | 2025 | $761,346 | September 15, 2025 | June 30, 2030 | CHANDRA, DIVAY | reporter.nih.gov |
| Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2023 | $760,358 | July 1, 2023 | September 14, 2023 | SERBAN, KARINA | reporter.nih.gov |
| Integrative network-based analysis of multi-omics data to elucidate the molecular connection between asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $756,000 | July 18, 2020 | June 30, 2026 | HALU, ARDA | reporter.nih.gov |
| A Randomized Controlled Trial of Home Air Purification for Eosinophilic COPD | NIH | National Institute of Environmental Health Sciences | 2025 | $754,541 | May 15, 2020 | February 28, 2027 | RICE, MARY B | reporter.nih.gov |
| Nuclease free gene editing approaches to treat alpha-1 antitrypsin disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $753,750 | May 27, 2013 | December 31, 2023 | FLOTTE, TERENCE R. | reporter.nih.gov |
| Early Life Predictors of Airway to Lung Dysanapsis | NIH | National Heart, Lung, and Blood Institute | 2024 | $753,018 | September 17, 2024 | August 31, 2025 | LOVINSKY-DESIR, STEPHANIE | reporter.nih.gov |
| Improving Participation in Pulmonary Rehabilitation through Peer-Support and Storytelling | NIH | National Heart, Lung, and Blood Institute | 2021 | $751,646 | September 1, 2021 | August 31, 2022 | LINDENAUER, PETER KYLE | reporter.nih.gov |
| Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $751,239 | February 1, 2019 | August 31, 2021 | ORTEGA, VICTOR E. | reporter.nih.gov |
| Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $749,520 | April 1, 2022 | March 31, 2027 | MOLL, MATTHEW R | reporter.nih.gov |
| Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $747,000 | July 1, 2023 | June 30, 2026 | LI, XIN | reporter.nih.gov |
| Mid-Career Mentoring Award in Palliative Care, Aging, and Cognitive Impairment | NIH | National Institute on Aging | 2022 to 2025 | $746,732 | August 15, 2022 | May 31, 2027 | BEKELMAN, DAVID B. | reporter.nih.gov |
| EpiGNOME: Epigenetic Graphical Networks Of Methylation Effectors for COPD Progression | NIH | National Heart, Lung, and Blood Institute | 2025 | $744,761 | January 1, 2025 | December 31, 2028 | BENOS, PANAGIOTIS V | reporter.nih.gov |
| COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS | NIH | National Heart, Lung, and Blood Institute | 2021 | $739,755 | July 1, 2021 | June 15, 2022 | BENOS, PANAGIOTIS V | reporter.nih.gov |
| Research training in chronic, non-communicable respiratory diseases in Peru | NIH | Fogarty International Center | 2021 to 2023 | $728,825 | September 15, 2019 | May 31, 2025 | CHECKLEY, WILLIAM | reporter.nih.gov |
| Optimizing Effectiveness and Implementation of COPD Self-Management Treatment | NIH | National Heart, Lung, and Blood Institute | 2025 | $725,088 | March 15, 2025 | November 30, 2029 | MATHEW, AMANDA R | reporter.nih.gov |
| Resolution of Epithelial Cell Hyperplasia in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $724,538 | July 1, 2003 | May 31, 2024 | TESFAIGZI, YOHANNES | reporter.nih.gov |
| Climate Change and Longitudinal Lung Function | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $723,929 | May 15, 2024 | April 30, 2028 | COLLACO, JOSEPH MICHAEL | reporter.nih.gov |
| Reducing Polypharmacy and Fall Risk for Multi-Morbid Adults with Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $723,833 | September 1, 2022 | August 31, 2026 | MCDERMOTT, CARA LYN | reporter.nih.gov |
| Mechanisms of Airway Epithelial Injury and Response | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $720,000 | September 23, 2019 | August 31, 2024 | WATERMAN, JENORA | reporter.nih.gov |
| CT-Derived Functional Imaging for Predicting Disease Progression in COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $713,348 | April 1, 2024 | March 31, 2028 | CASTILLO, EDWARD | reporter.nih.gov |
| Sex, HIV, and Lung Health Across the Life Course: The Uganda Lung Health Study | NIH | National Heart, Lung, and Blood Institute | 2025 | $712,628 | September 15, 2025 | June 30, 2030 | NORTH, CRYSTAL | reporter.nih.gov |
| Post-transcriptional regulatory networks in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $708,063 | May 1, 2025 | February 28, 2030 | PLATIG, JOHN | reporter.nih.gov |
| Defining cardinal functions of lung progenitors during regeneration | NIH | National Heart, Lung, and Blood Institute | 2025 | $701,795 | September 1, 2025 | June 30, 2029 | MORRISEY, EDWARD E | reporter.nih.gov |
| Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $699,840 | July 1, 2020 | October 31, 2025 | LABAKI, WASSIM W | reporter.nih.gov |
| Suppression of alveolar stem cells by tissue-resident lymphocytes in emphysema | NIH | National Heart, Lung, and Blood Institute | 2025 | $684,814 | January 1, 2025 | November 30, 2028 | PENG, TIEN | reporter.nih.gov |
| The role of COPD genetic risk factor HHIP on lymphocytic inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $678,240 | April 1, 2020 | March 31, 2026 | YUN, JEONG H | reporter.nih.gov |
| Maintenance of the alveolar niche in emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 | $676,835 | August 22, 2018 | June 30, 2022 | PENG, TIEN | reporter.nih.gov |
| The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers | NIH | National Heart, Lung, and Blood Institute | 2021 | $676,308 | February 1, 2013 | June 30, 2024 | WASHKO, GEORGE R | reporter.nih.gov |
| Genetic mechanisms underlying maladaptive respiratory responses to air pollution | NIH | National Institute of Environmental Health Sciences | 2025 | $671,165 | January 1, 2025 | October 31, 2029 | KELADA, SAMIR | reporter.nih.gov |
| The effect of household air pollution on lung function growth in infants with pneumonia in sub-Saharan Africa. | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $670,862 | March 14, 2024 | February 28, 2025 | MOSCHOVIS, PETER P | reporter.nih.gov |
| Inhaled Stressors and Lung Aging | NIH | National Institute on Aging | 2025 | $667,664 | August 15, 2025 | July 31, 2027 | KLIMENT, CORRINE R | reporter.nih.gov |
| Molecular regulation of cell fate and progenitor function in the distal human respiratory airways | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $667,440 | April 1, 2022 | March 31, 2027 | BASIL, MARIA CIOCCA | reporter.nih.gov |
| Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $667,118 | September 21, 2018 | May 31, 2024 | WENDT, CHRIS H | reporter.nih.gov |
| Air Pollution and Mortality Risk in Veterans with Chronic Respiratory Disease: Assessing the Role of Individual and Place-Based Risk Factors | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $666,466 | August 7, 2024 | July 31, 2029 | BERMAN, JESSE DAVID | reporter.nih.gov |
| Classifying malignant pulmonary nodules using biophysics-enhanced artificial intelligence | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $660,000 | September 1, 2021 | August 31, 2025 | NIA, HADI TAVAKOLI | reporter.nih.gov |
| AdvanCing High quality COPD care for people with immune dysfunction by implementing Evidence-based management through proactive E-consults (ACHIEVE) | NIH | National Heart, Lung, and Blood Institute | 2021 | $658,660 | August 15, 2018 | May 31, 2025 | AU, DAVID H | reporter.nih.gov |
| Activated Neutrophilic Exosome as Biomarker and Therapeutic Target in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $658,584 | June 15, 2020 | May 31, 2026 | RUSSELL, DEREK | reporter.nih.gov |
| An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $650,726 | May 1, 2018 | December 31, 2022 | BATMANGHELICH, KAYHAN | reporter.nih.gov |
| Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $642,128 | January 1, 2022 | December 31, 2026 | LAFON, DAVID CARDY | reporter.nih.gov |
| Mechanosensitive mechanism of angiogenesis in the lung | NIH | National Heart, Lung, and Blood Institute | 2025 | $618,838 | August 20, 2025 | May 31, 2029 | MAMMOTO, AKIKO | reporter.nih.gov |
| Role of Lung MSC in Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 | $616,754 | March 21, 2019 | December 31, 2021 | MAJKA, SUSAN M | reporter.nih.gov |
| Fungal Translocation in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $616,495 | April 15, 2022 | March 31, 2027 | BON, JESSICA | reporter.nih.gov |
| Defining Pathways in COPD Patient Oriented Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $610,152 | July 1, 2017 | July 31, 2027 | HAN, MEILAN K | reporter.nih.gov |
| Wood Smoke and Chronic Mucous Hypersecretion | NIH | National Heart, Lung, and Blood Institute | 2021 | $608,377 | August 1, 2018 | May 31, 2024 | TESFAIGZI, YOHANNES | reporter.nih.gov |
| Mentoring Research in Precision Medicine for Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $604,965 | April 28, 2017 | March 31, 2027 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| Mechanism of pathogenic macrophage activation in emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 | $597,019 | February 1, 2018 | January 31, 2023 | MITZNER, WAYNE | reporter.nih.gov |
| Determinants of Altered Brain Structure and Function in Smokers with COPD-Related Lung Pathophysiology | NIH | National Heart, Lung, and Blood Institute | 2021 | $595,553 | May 1, 2017 | April 30, 2025 | HOTH, KARIN F | reporter.nih.gov |
| BIOSPECIMEN REPOSITORY STORAGE SERVICES | NIH | National Heart, Lung, and Blood Institute | 2025 | $593,062 | May 1, 2023 | October 31, 2025 | FERINDE, JOHN | reporter.nih.gov |
| Effectiveness of Low-dose Theophylline for the Management of biomass-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $590,723 | July 15, 2019 | June 30, 2025 | SIDDHARTHAN, TRISHUL | reporter.nih.gov |
| The Pulmonary Vasculature and Platelets in Emphysema and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $589,493 | May 1, 2019 | April 30, 2025 | PISTENMAA, CARRIE L | reporter.nih.gov |
| Developmental Origins of COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $585,380 | April 1, 2025 | March 31, 2027 | BENJAMIN, JOHN | reporter.nih.gov |
| Clinical Implications of Bronchiectasis in Smokers | NIH | National Heart, Lung, and Blood Institute | 2021 | $585,156 | June 20, 2017 | April 30, 2023 | DIAZ, ALEJANDRO | reporter.nih.gov |
| Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $583,881 | June 1, 2020 | July 31, 2022 | ZAHID, MALIHA | reporter.nih.gov |
| Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual | NIH | Fogarty International Center | 2022 to 2023 | $573,075 | July 1, 2022 | June 30, 2025 | KAYONGO, ALEX | reporter.nih.gov |
| Harnessing Inflammatory Macrophages to Thwart Lung Disease Caused by Chronic Ozone Exposure | NIH | National Institute of Environmental Health Sciences | 2022 | $568,387 | February 15, 2022 | November 30, 2022 | LASKIN, DEBRA L | reporter.nih.gov |
| SCH: Pennsylvania Asthma-COPD Syndromic Surveillance (PASS) | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $568,292 | July 6, 2024 | April 30, 2028 | CHOI, HYUNOK | reporter.nih.gov |
| Statistical physics and network-based approaches for elucidating molecular biomarkers of COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $567,000 | July 1, 2023 | June 30, 2028 | WANG, XUWEN | reporter.nih.gov |
| Impact of virome on microbial communities in the respiratory tract | NIH | National Heart, Lung, and Blood Institute | 2021 | $566,258 | May 1, 2017 | August 31, 2022 | BOMBERGER, JENNIFER MELINDA | reporter.nih.gov |
| SCH: A multimodal wearable device to measure physiologic coupling | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $565,893 | September 17, 2024 | June 30, 2028 | MARKVICKA, ERIC | reporter.nih.gov |
| Statistical Standardization of CT for the Analysis of Parenchymal Injury Progression in Smokers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $563,760 | August 1, 2019 | January 12, 2025 | VEGAS SANCHEZ-FERRERO, GONZALO | reporter.nih.gov |
| Interpretable graphical models for large multi-modal COPD data | NIH | National Heart, Lung, and Blood Institute | 2021 | $559,193 | July 1, 2015 | June 15, 2022 | BENOS, PANAGIOTIS V | reporter.nih.gov |
| Linking endotype and phenotype to understand COPD heterogeneity via deep learning and network science | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $534,600 | January 1, 2023 | December 31, 2027 | MAIORINO, ENRICO | reporter.nih.gov |
| Identifying patients at risk of post-tuberculosis lung disease using novel cough and adherence predictors | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $523,260 | July 20, 2023 | July 31, 2028 | HUDDART, SOPHIE | reporter.nih.gov |
| Lung Biomechanics and Disease Progression in SPIROMICS | NIH | National Heart, Lung, and Blood Institute | 2021 | $513,856 | August 1, 2018 | May 31, 2024 | REINHARDT, JOSEPH M | reporter.nih.gov |
| Climate Variability and Respiratory Health in Asthma and COPD | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $512,404 | April 1, 2024 | March 31, 2029 | NASSIKAS, NICHOLAS | reporter.nih.gov |
| Active for Life: Chronic Obstructive Pulmonary Disease | NIH | National Institute of Nursing Research | 2021 | $507,357 | February 17, 2017 | April 30, 2023 | LARSON, JANET L. | reporter.nih.gov |
| Alveolar Macrophage Iron Overload in COPD Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $507,060 | August 1, 2023 | July 30, 2028 | ZHANG, WILLIAM ZHENGYANG | reporter.nih.gov |
| The role of endothelial derived Leucine-Rich Alpha-2-Glycoprotein 1 (LRG1) in the pathogenesis of COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $505,440 | August 1, 2022 | July 31, 2027 | RACANELLI, ALEXANDRA CHRISTIN | reporter.nih.gov |
| Silent Zones of Lung Disease in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $504,411 | January 1, 2023 | December 31, 2027 | BODDULURI, SANDEEP | reporter.nih.gov |
| Development of a Community Health Worker-Led Stress Reduction Intervention for Low-Income COPD Patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $501,812 | August 1, 2020 | July 31, 2025 | PAREKH, TRISHA M | reporter.nih.gov |
| The Role of Airway Morphology in Environmental LungDiseases | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $500,901 | September 1, 2019 | August 31, 2025 | SACK, CORALYNN SHAYNA | reporter.nih.gov |
| Postnatal Alveolar Formation | NIH | National Heart, Lung, and Blood Institute | 2021 | $498,360 | September 1, 2018 | July 31, 2024 | MINOO, PARVIZ MINOO | reporter.nih.gov |
| The transcription factor Miz1-mediated mechanism of lung aging | NIH | National Heart, Lung, and Blood Institute | 2021 | $490,293 | March 15, 2020 | May 31, 2023 | LIU, JING | reporter.nih.gov |
| Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $489,324 | July 1, 2023 | June 30, 2028 | KONSTANTINIDIS, IOANNIS | reporter.nih.gov |
| Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $488,666 | April 5, 2023 | March 31, 2026 | GUPTE, AKSHAY NITIN | reporter.nih.gov |
| Managing the Folding Landscape in Alpha1 Liver-Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $483,750 | July 15, 2018 | April 30, 2023 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| Improving COPD Outcomes: Using Real-World Data to Analyze Treatment Effectiveness, Safety, and Adherence | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $477,408 | December 19, 2022 | November 30, 2025 | FELDMAN, WILLIAM BRAND | reporter.nih.gov |
| The Impact of Underlying Behavioral Mechanisms on a Home-Based Pulmonary Rehabilitation Program | NIH | National Heart, Lung, and Blood Institute | 2024 | $477,290 | September 24, 2024 | August 31, 2025 | FORTUNE, EMMA | reporter.nih.gov |
| Mannose binding lectin-dependent complement activation in emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $475,956 | December 17, 2018 | November 30, 2023 | SERBAN, KARINA | reporter.nih.gov |
| Novel Technologies for Detection and Monitoring of Lung Disease | NIH | National Library of Medicine | 2025 | $471,544 | September 16, 2025 | September 15, 2026 | BHATT, SHIV KUMAR | reporter.nih.gov |
| Development of PAR2 Pepducins for the Treatment of COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $468,369 | September 15, 2025 | October 31, 2026 | COVIC, LIDIJA | reporter.nih.gov |
| Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma | NIH | National Heart, Lung, and Blood Institute | 2021 | $465,888 | September 20, 2018 | August 31, 2023 | CHU, HONG W | reporter.nih.gov |
| SCH: Leveraging Clinical Time Series to Learn Optimal Treatment of Acute Dyspnea | NIH | National Library of Medicine | 2021 to 2022 | $460,834 | September 10, 2019 | July 31, 2025 | WIENS, JENNA | reporter.nih.gov |
| Commercialization of a CT-based Technique for BOS Assessment | NIH | National Heart, Lung, and Blood Institute | 2021 | $459,828 | August 1, 2018 | May 31, 2022 | LUDWIG, KAI DAVID | reporter.nih.gov |
| Preventing hospitalizations for COPD exacerbations due to air pollution from wildfire smoke - LE Supplement | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $459,163 | April 1, 2024 | July 31, 2026 | MYERS, LAURA CHRISTINE | reporter.nih.gov |
| Reference strains of Mycobacteroides abscessus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $448,849 | April 1, 2021 | March 31, 2024 | LAMICHHANE, GYANU | reporter.nih.gov |
| Complement driven innate and adaptive autoreactivity in lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 | $444,968 | March 3, 2021 | June 30, 2025 | ATKINSON, CARL | reporter.nih.gov |
| Flexible causal inference methods for estimating longitudinal effects of air pollution on chronic lung disease | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $443,079 | August 16, 2022 | May 31, 2027 | MALINSKY, DANIEL | reporter.nih.gov |
| Hox5 gene regulation of lung fibroblasts and distal lung extracellular matrix | NIH | National Heart, Lung, and Blood Institute | 2021 | $442,787 | September 1, 2018 | June 30, 2023 | WELLIK, DENEEN M | reporter.nih.gov |
| Impact of Wildfire Smoke on Lung Injury | NIH | National Institute of Environmental Health Sciences | 2024 | $433,950 | September 1, 2024 | August 31, 2026 | MILLER, LISA A | reporter.nih.gov |
| Extracellular Matrix Regulation of Airway Epithelial Homeostasis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $433,174 | September 1, 2024 | June 30, 2027 | WEISS, DANIEL J | reporter.nih.gov |
| Alteration of bronchial epithelium host defenses by marijuana and vaping preparations | NIH | National Institute on Drug Abuse | 2023 to 2024 | $433,125 | September 15, 2023 | August 31, 2025 | CORMET-BOYAKA, ESTELLE A | reporter.nih.gov |
| The Pulmonary Lymphatics in Inflammation and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $429,672 | July 23, 2019 | June 30, 2024 | REED, HASINA OUTTZ | reporter.nih.gov |
| Changes in Exposures to PFAS, Metals, Dioxins, and Furans following Cessation of Open Burning of Munitions Wastes at a Hazardous Waste Thermal Treatment Facility | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $426,808 | April 16, 2024 | August 31, 2026 | RICHMOND-BRYANT, JENNIFER | reporter.nih.gov |
| Wirelessly Actuated Ciliary Stent for Minimally Invasive Treatment of Cilia Dysfunction | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 to 2025 | $426,444 | August 1, 2024 | April 30, 2027 | DONG, XIAOGUANG | reporter.nih.gov |
| Gene Therapy for Alpha 1-Antitrypsin Deficiency | NIH | National Heart, Lung, and Blood Institute | 2024 | $422,895 | May 15, 2024 | April 30, 2025 | CRYSTAL, RONALD G | reporter.nih.gov |
| Actin-myosin contractility promotes the development of chronic bronchitis | NIH | National Heart, Lung, and Blood Institute | 2021 | $419,120 | February 1, 2017 | January 31, 2023 | SIDHAYE, VENKATARAMANA K | reporter.nih.gov |
| Regulation of chronic obstructive pulmonary disease by parsnip polyphenols | NIH | National Center for Complementary & Integrative Health | 2025 | $415,780 | September 1, 2025 | August 31, 2027 | KIM, KEE-HONG | reporter.nih.gov |
| Heat-shock protein 90 modulates goblet cell metaplasia in human airway epithelia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $414,492 | February 1, 2019 | January 31, 2024 | PEZZULO, ALEJANDRO ANTONIO | reporter.nih.gov |
| Molecular mechanisms underlying persistent effects of early life exposure on lung function and remodeling | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $414,368 | July 23, 2025 | June 30, 2027 | JI, HONG | reporter.nih.gov |
| The role of PUMA in the progression of cigarette smoking-induced COPD | NIH | National Heart, Lung, and Blood Institute | 2023 | $413,958 | September 22, 2023 | August 31, 2025 | CHEN, DONGSHI | reporter.nih.gov |
| Impact of hyperglycemia on the pathogenesis of chronic bacterial lung infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $411,237 | June 1, 2023 | May 31, 2026 | WOLFGANG, MATTHEW C | reporter.nih.gov |
| Innate immune cell contribution in wood smoke induced effects to pulmonary function | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $406,500 | March 17, 2021 | February 29, 2024 | MIGLIACCIO, CHRISTOPHER TODD | reporter.nih.gov |
| Genetic and Transcriptomic Resilience in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $404,128 | January 15, 2024 | December 31, 2028 | GHOSH, AUYON | reporter.nih.gov |
| Commercial Translation of Biomarker-based Platform for Personalized Forecasting of Rapid Lung Function Decline | NIH | National Heart, Lung, and Blood Institute | 2021 | $397,500 | September 1, 2020 | July 31, 2023 | ZIADY, ASSEM G | reporter.nih.gov |
| COPDHeart: Improving Cardiovascular Health Among Black Adults with COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $394,200 | September 12, 2024 | July 31, 2029 | KRISHNAN, JAMUNA | reporter.nih.gov |
| A LncRNA in Pulmonary Mucosal Immunity and HIV-Associated Comorbidities | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $387,607 | September 3, 2020 | August 31, 2023 | LAKSHMANA, MADEPALLI KRISHNAPPA | reporter.nih.gov |
| Genetic Epidemiology of Respiratory Function in Former Preterm Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $387,534 | January 15, 2018 | July 31, 2023 | HAYDEN, LYSTRA P. | reporter.nih.gov |
| Electronic Cigarette Vapor Inhalation Adversely Affects Lung Cellular and Physiologic Function and Alters Systemic Inflammatory Pathways | NIH | National Heart, Lung, and Blood Institute | 2021 | $387,500 | April 1, 2017 | December 31, 2022 | CROTTY ALEXANDER, LAURA ELISE | reporter.nih.gov |
| Capnography-Assisted Learned, Monitored (CALM) Breathing Therapy for COPD | NIH | National Center for Complementary & Integrative Health | 2021 | $383,174 | September 1, 2021 | August 31, 2023 | NORWEG, ANNA MIGLIORE | reporter.nih.gov |
| Next-generation Lasers for Enabling Ultrafast Functional Pulmonary MRI | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $378,602 | September 1, 2024 | June 30, 2027 | CHEKMENEV, EDUARD | reporter.nih.gov |
| Implementation and validation of a lung x-ray interferometry imaging system, with applications to COPD, COVID-19 and other lung diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $377,996 | September 1, 2022 | August 31, 2024 | MATTHEWS, KENNETH L | reporter.nih.gov |
| The impact of the oral microbiome on pulmonary function among people with HIV in Botswana | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $374,184 | February 1, 2024 | January 31, 2029 | PATEL, SWETA MAHESH | reporter.nih.gov |
| Structural and Funcional Vascular Phenotyping in Smokers with Pulmonary Hypertension using Artificial Intelligence | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $374,160 | December 1, 2023 | November 30, 2028 | NARDELLI, PIETRO | reporter.nih.gov |
| SMART POR: Supporting and Mentoring Across Respiratory Topics in Patient Oriented Research | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $363,624 | March 1, 2023 | February 29, 2028 | PRESS, VALERIE G | reporter.nih.gov |
| A HANDS-FREE LUNG AND CARDIOVASCULAR ASSESSMENT DEVICE (LCAD) FOR THE REMOTE CARE OF PATIENTS WITH CHRONIC CARDIOPULMONARY CONDITIONS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $361,222 | August 1, 2022 | April 30, 2023 | ORTEGA, WILMAN RENE | reporter.nih.gov |
| Arsenic exposure, CC16 and its effect on pulmonary function | NIH | National Institute of Environmental Health Sciences | 2021 | $345,375 | May 1, 2017 | November 30, 2022 | LANTZ, ROBERT CLARK | reporter.nih.gov |
| The Reduction of NLRX1 and Its Role in Pulmonary Aging | NIH | National Institute on Aging | 2021 | $343,373 | August 15, 2016 | August 31, 2022 | KANG, MIN-JONG | reporter.nih.gov |
| Pulmonary Epithelial TRPV3 and Wood Smoke Injury | NIH | National Institute of Environmental Health Sciences | 2021 | $343,125 | March 1, 2017 | February 28, 2023 | REILLY, CHRISTOPHER A | reporter.nih.gov |
| Clinical significance and genetic determinants of novel imaging measures of emphysema distribution in 9,743 smokers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $341,278 | July 1, 2018 | October 31, 2023 | EL BOUEIZ, ADEL | reporter.nih.gov |
| Leukotriene B4 and IL-8 in alpha-1 heterozygotes (PI*MZ genotype) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $341,121 | April 1, 2024 | March 31, 2029 | TEJWANI, VICKRAM | reporter.nih.gov |
| Characterization of Early Response to Chronic Lung Injury using Chest CT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $340,640 | January 1, 2019 | December 3, 2022 | ASH, SAMUEL | reporter.nih.gov |
| Loss of progenitor function accelerates lung aging | NIH | National Institute on Aging | 2021 | $336,200 | September 1, 2021 | June 14, 2023 | MAJKA, SUSAN M | reporter.nih.gov |
| All-in-one measurement and exercise respiratory strength trainer with biofeedback and adherence tracking capability. | NIH | National Heart, Lung, and Blood Institute | 2024 | $333,810 | September 10, 2024 | September 9, 2025 | ZAMBRANA, NELSON | reporter.nih.gov |
| A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $329,875 | September 1, 2024 | August 31, 2025 | GAO, XIANG | reporter.nih.gov |
| The Role of Adenine Nucleotide Translocase in the Protection of Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease (COPD) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $325,080 | August 16, 2018 | July 31, 2023 | KLIMENT, CORRINE R | reporter.nih.gov |
| A Stand Alone Wearable for Tracking Environmental Exposure and Evaluating Respiratory Response | NIH | National Heart, Lung, and Blood Institute | 2024 | $324,770 | September 17, 2024 | September 14, 2025 | CHAPMAN, TERRY | reporter.nih.gov |
| Sex chromosome gene regulatory networks and COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $324,000 | May 1, 2023 | February 28, 2025 | LOPES-RAMOS, CAMILA | reporter.nih.gov |
| Methods for Unraveling the Impact of Dietary Xenobiotics on COPD Exacerbations with Multi-Dimensional Networks | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $323,626 | April 1, 2024 | January 31, 2029 | MENICHETTI, GIULIA | reporter.nih.gov |
| GEMSSTAR PERSPIRE-COPD | NIH | National Institute on Aging | 2023 to 2024 | $322,000 | September 1, 2023 | May 31, 2026 | MOSHER, CHRISTOPHER | reporter.nih.gov |
| Developing non-anticoagulant recombinant heparin for treating the COPD Pathogenic Triad | NIH | National Heart, Lung, and Blood Institute | 2022 | $321,866 | February 5, 2022 | May 31, 2024 | GLASS, CHARLES ALEXANDER | reporter.nih.gov |
| Improving the Generalizability of Deep Neural Networks by Teaching Single Nucleotide Polymorphisms Associated with LDCT Features | NIH | National Cancer Institute | 2023 to 2025 | $312,102 | September 1, 2023 | August 31, 2027 | MASQUELIN, AXEL HERVE PATRICK | reporter.nih.gov |
| A breakthrough mobile phone technology that aids in early detection of COPD - TABA fund supplement | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $305,925 | June 1, 2024 | September 14, 2024 | WOLFSON, DAVID | reporter.nih.gov |
| An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD | NIH | National Heart, Lung, and Blood Institute | 2023 | $295,274 | March 1, 2023 | July 31, 2023 | NICOLA, TEODORA | reporter.nih.gov |
| Restoring mucociliary clearance apparatus to mitigate lung inflammation in the context of HIV and cigarette smoke | NIH | National Institute on Drug Abuse | 2022 to 2023 | $295,000 | August 1, 2022 | July 31, 2025 | CHINNAPAIYAN, SRINIVASAN | reporter.nih.gov |
| Development of a CO2-bicarbonate combined membrane capture system for accessible treatment of acute respiratory failure. | NIH | National Heart, Lung, and Blood Institute | 2021 | $293,121 | September 17, 2021 | May 31, 2022 | CHANG, BRIAN YALE | reporter.nih.gov |
| A Low-Cost Wearable Connected Health Device for Monitoring Environmental Pollution Triggers of Asthma in Communities with Health Disparities | NIH | National Heart, Lung, and Blood Institute | 2023 | $291,896 | September 15, 2023 | September 14, 2025 | NAISHADHAM, KRISHNA | reporter.nih.gov |
| Identifying palliative care needs among hospitalized patients with chronic obstructive pulmonary disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $286,397 | September 15, 2018 | August 31, 2023 | COURTRIGHT, KATHERINE RINALDI | reporter.nih.gov |
| Glycoengineering of CHO cells to express recombinant alpha-1 antitrypsin | NIH | National Heart, Lung, and Blood Institute | 2022 | $274,441 | September 22, 2022 | September 21, 2024 | LEWIS, NATHAN ENOCH | reporter.nih.gov |
| A smart wearable contact microphone patch for extended and remote monitoring of lung functions | NIH | National Heart, Lung, and Blood Institute | 2024 | $269,922 | September 17, 2024 | September 30, 2025 | WEN, HAORAN | reporter.nih.gov |
| Robust Detection of Early Small Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $268,500 | March 1, 2021 | January 12, 2025 | VEGAS SANCHEZ-FERRERO, GONZALO | reporter.nih.gov |
| Role of specialized pro-resolving mediators of inflammation resolution in emphysema: analyses of SPIROMICS and LEEP | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $262,818 | August 1, 2024 | July 31, 2026 | BOSE, SONALI | reporter.nih.gov |
| Building a Digital Respiratory Disease Framework for COPD management in Central Appalachia | NIH | National Institute on Minority Health and Health Disparities | 2022 | $259,453 | September 26, 2022 | November 30, 2023 | KISER, STARLA | reporter.nih.gov |
| Mitochondrial Derived Peptides in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $258,516 | July 15, 2025 | June 30, 2027 | KLIMENT, CORRINE R | reporter.nih.gov |
| Mentoring in Patient Oriented Research in Lung Disease through a Sex and Gender Lens | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $257,300 | January 1, 2024 | December 31, 2028 | DEMEO, DAWN L | reporter.nih.gov |
| Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $251,250 | January 1, 2022 | December 31, 2023 | KAMINSKI, NAFTALI | reporter.nih.gov |
| Local cellular communication networks in COPD endotypes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $251,250 | April 15, 2024 | March 31, 2027 | SAULER, MAOR | reporter.nih.gov |
| Molecular Analysis of Airway Secretory Cells in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $249,000 | February 21, 2025 | January 31, 2028 | HU, YAN | reporter.nih.gov |
| Role of platelet-eosinophil interactions in COPD morbidity | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $245,626 | April 1, 2024 | March 31, 2027 | FAWZY, ASHRAF | reporter.nih.gov |
| Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations (INSPIRE-COPD-E). | NIH | National Institute on Aging | 2025 | $243,000 | September 1, 2025 | June 30, 2030 | MOSHER, CHRISTOPHER | reporter.nih.gov |
| Mechanistic Effects of Health Coaching to reduce COPD Hospitalizations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $240,890 | May 1, 2018 | October 1, 2023 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Isolated Abnormality in the Diffusion Capacity for Carbon Monoxide in People Living with HIV – Epidemiology, Etiology and Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $240,190 | September 1, 2022 | June 30, 2025 | BYANOVA, KATERINA L. | reporter.nih.gov |
| Circulating immunoactive small RNAs in COPD as biomarkers. | NIH | National Heart, Lung, and Blood Institute | 2025 | $234,000 | September 1, 2025 | August 31, 2027 | SHIGEMATSU, MEGUMI HAMASAKI | reporter.nih.gov |
| CT-based Characterization of Lung Volume-determined Airway and Chest Wall Deformation Interdependences in COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $233,250 | September 1, 2024 | June 30, 2027 | SAHA, PRANAV K. | reporter.nih.gov |
| Inhaled Pitavastatin for the Treatment of Asthma: A New Therapeutic Paradigm | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $231,617 | February 1, 2025 | January 31, 2027 | ZEKI, AMIR A. | reporter.nih.gov |
| Lung deposition dose of black carbon as a driver of health Disparities | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $228,750 | April 15, 2024 | March 31, 2027 | LENG, SHUGUANG | reporter.nih.gov |
| Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI | NIH | National Heart, Lung, and Blood Institute | 2021 | $228,593 | July 22, 2020 | June 30, 2024 | CHEKMENEV, EDUARD | reporter.nih.gov |
| Immunogenetic risk factors for exacerbations in African American people with COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $222,750 | August 1, 2025 | July 31, 2027 | LAFON, DAVID CARDY | reporter.nih.gov |
| Molecular Analysis of Airway Secretory Cells in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $217,138 | April 1, 2023 | February 20, 2025 | HU, YAN | reporter.nih.gov |
| Next-generation ultrafast functional 3D pulmonary imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $209,784 | September 7, 2021 | September 6, 2024 | ARIYASINGHA U W, NUWANDI M | reporter.nih.gov |
| Implementation of interprofessional training to improve uptake of noninvasive ventilation in patients hospitalized with severe COPD exacerbation | NIH | National Heart, Lung, and Blood Institute | 2021 | $208,241 | May 15, 2019 | March 4, 2022 | STEFAN, MIHAELA S | reporter.nih.gov |
| Effects of Electronic Cigarette Use on Smokers with Mild to Moderate Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $200,879 | January 1, 2018 | February 1, 2022 | KALKHORAN, SARA M | reporter.nih.gov |
| Financial Toxicity in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $198,724 | July 1, 2025 | June 30, 2026 | MALLYA, SONAL | reporter.nih.gov |
| The Role of Diet in COPD Rehospitalization | NIH | National Heart, Lung, and Blood Institute | 2025 | $198,654 | August 1, 2025 | July 31, 2030 | BELZ, DANIEL CARPENTER | reporter.nih.gov |
| Cigarette smoke influences alveolar type II cell-derived exosomes | NIH | National Institute of Environmental Health Sciences | 2021 | $197,088 | May 15, 2020 | October 31, 2023 | BAHMED, KARIM | reporter.nih.gov |
| Comprehensive Home-based Self-management Support for COPD Patients | NIH | National Heart, Lung, and Blood Institute | 2021 | $196,340 | June 15, 2019 | April 30, 2022 | FEDERMAN, ALEX D | reporter.nih.gov |
| Context matters: Network modeling of COPD regulatory variants across tissues and exposures | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $195,824 | September 1, 2018 | March 31, 2023 | PLATIG, JOHN | reporter.nih.gov |
| Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $193,906 | January 1, 2022 | June 30, 2023 | LI, XIN | reporter.nih.gov |
| Right Ventricular Response to Exercise Among Patients with Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $190,825 | August 1, 2025 | May 1, 2030 | FORBES, LINDSAY M | reporter.nih.gov |
| Integrative omics pipeline to identify novel COPD genes and pathways | NIH | National Heart, Lung, and Blood Institute | 2021 | $188,999 | May 1, 2017 | April 30, 2023 | MORROW, JARRETT | reporter.nih.gov |
| Competitive Bidding in Medicare and the Implications for Home Oxygen Therapy in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 | $188,568 | April 26, 2023 | July 31, 2023 | DUAN, KEVIN | reporter.nih.gov |
| Evaluating the Impact of ACEs Screening and Behavioral-Social Support on Obstructive Lung Disease Health Outcomes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $186,896 | September 1, 2024 | August 31, 2027 | MARTINEZ, ADALI | reporter.nih.gov |
| Deep Learning and Fluid Dynamics Based Phenotyping of Expiratory Central Airway Collapse | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $185,497 | September 9, 2019 | May 31, 2023 | BHATT, SURYA P. | reporter.nih.gov |
| The Role of Iron Deficiency in COPD Morbidity | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $180,916 | July 1, 2023 | June 30, 2025 | KUNITOMO, YUKIKO | reporter.nih.gov |
| Defining Combined Pulmonary Fibrosis and Emphysema (CPFE) using Quantitative CT Imaging | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $173,667 | September 10, 2024 | July 9, 2026 | WANG, JENNIFER MIN | reporter.nih.gov |
| Multi-omic Subtyping of Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $172,800 | July 1, 2017 | November 30, 2022 | HOBBS, BRIAN DANIEL | reporter.nih.gov |
| Physiologic Predictors of Respiratory Failure in Patients Presenting with Dyspnea | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $172,792 | July 1, 2023 | June 30, 2025 | MCGUIRE, WILLIAM CAMERON | reporter.nih.gov |
| UAB Mentoring Program in COPD Patient Oriented Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $172,374 | January 15, 2018 | December 31, 2023 | DRANSFIELD, MARK T | reporter.nih.gov |
| Computed tomography for early detection and phenotyping of pulmonary hypertension associated with chronic obstructive pulmonary disease with implications for treatment | NIH | National Heart, Lung, and Blood Institute | 2025 | $171,858 | August 1, 2025 | July 31, 2030 | JOHNSON, SHELSEY WEINSTEIN | reporter.nih.gov |
| Characterizing chronic lung disease in youth living with HIV: quantitative chest CT analyses | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $169,857 | April 1, 2022 | March 31, 2024 | ATTIA, ENGI FAROUK | reporter.nih.gov |
| Development of a Community Health Worker-Led Stress Reduction Intervention for Low-Income COPD Patients | NIH | National Heart, Lung, and Blood Institute | 2021 | $168,802 | August 1, 2020 | July 31, 2022 | PAREKH, TRISHA M | reporter.nih.gov |
| Optimizing self-management COPD treatment through the American Lung Association Helpline | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $168,794 | April 1, 2021 | March 31, 2024 | MATHEW, AMANDA R | reporter.nih.gov |
| MIF and DNA repair in the emphysematous lung | NIH | National Heart, Lung, and Blood Institute | 2021 | $168,480 | January 1, 2017 | December 31, 2021 | SAULER, MAOR | reporter.nih.gov |
| Paramedic Evaluation for Acute COPD Exacerbation: the PEACE Intervention | NIH | National Heart, Lung, and Blood Institute | 2025 | $167,398 | July 1, 2025 | June 30, 2030 | O'CONNOR, LAUREL | reporter.nih.gov |
| The Left and Right Ventricles in Sleep Apnea with COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $166,724 | August 16, 2024 | August 15, 2027 | RAPHELSON, JANNA | reporter.nih.gov |
| The Effect of Hyperoxia on Neonatal Respiratory Progenitor Cell Function | NIH | National Heart, Lung, and Blood Institute | 2025 | $166,395 | September 1, 2025 | August 31, 2030 | RAI, NOORALAM | reporter.nih.gov |
| Nocturnal hypoxemia dysregulates skeletal muscle protein homeostasis in COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $151,578 | January 1, 2025 | December 31, 2029 | ATTAWAY, AMY | reporter.nih.gov |
| Computational Breathing Model for Robust Lung Function Assessment | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $150,951 | August 1, 2025 | July 31, 2027 | CASTILLO, EDWARD | reporter.nih.gov |
| Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients | NIH | National Heart, Lung, and Blood Institute | 2021 | $148,123 | November 1, 2018 | July 31, 2023 | MATHEW, AMANDA R | reporter.nih.gov |
| Age-Dependent Effects of E-cigarette Vaping on Host Pathogen Defense | NIH | Office of the Director, National Institutes of Health | 2021 | $147,474 | September 15, 2017 | June 30, 2023 | ROYER, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Multi-omic network methods for mapping molecular trajectories of age-related lung diseases | NIH | National Heart, Lung, and Blood Institute | 2025 | $140,403 | August 1, 2025 | July 31, 2030 | SHUTTA, KATHERINE HOFF | reporter.nih.gov |
| Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $135,432 | September 1, 2020 | August 31, 2022 | GUPTE, AKSHAY NITIN | reporter.nih.gov |
| Assessment of microvascular volume in smokers using AI | NIH | National Heart, Lung, and Blood Institute | 2025 | $134,250 | February 1, 2025 | January 31, 2027 | NARDELLI, PIETRO | reporter.nih.gov |
| Patient oriented research and mentoring in COPD biomarker studies | NIH | National Heart, Lung, and Blood Institute | 2025 | $131,783 | February 1, 2025 | December 31, 2029 | HERSH, CRAIG P | reporter.nih.gov |
| A Mixed Methods Evaluation of Developing COPD Exacerbations in the MARC Cohort | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $127,596 | March 1, 2023 | June 30, 2024 | CASE, MEREDITH ANNE | reporter.nih.gov |
| Clonotyping Airway T-cells to Uncover Microbiome-Specific Inflammotypes in HIV-associated COPD | NIH | Fogarty International Center | 2025 | $124,524 | September 16, 2025 | August 31, 2030 | KAYONGO, ALEX | reporter.nih.gov |
| Hedgehog Signaling as a regulator of progenitor differentiation for organ maintenance and disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $123,000 | February 1, 2025 | November 30, 2026 | YANG, XINAN HOLLY | reporter.nih.gov |
| Understanding Dysregulated Crosstalk Between Regulatory T Cells and Lung Dendritic Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $120,500 | May 16, 2022 | July 15, 2025 | MENGISTU, DAWIT | reporter.nih.gov |
| Transcriptomic signatures of airway inflammation in acute respiratory diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $119,061 | March 1, 2020 | June 30, 2022 | SARMA, AARTIK | reporter.nih.gov |
| Understanding the interstitial phenotype of impaired respiratory health through CT imaging and blood biomarkers | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $116,648 | February 1, 2022 | July 31, 2023 | LIU, GABRIELLE | reporter.nih.gov |
| : Osteoporosis and Sarcopenia in COPD and CT-based Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2025 | $116,625 | February 1, 2025 | January 31, 2027 | SAHA, PRANAV K. | reporter.nih.gov |
| Characterizing determinants of cellular senescence and epigenetic dysregulation on tobacco smoke exposure in lung | NIH | National Heart, Lung, and Blood Institute | 2025 | $113,683 | September 1, 2025 | July 31, 2027 | KAUR, GAGANDEEP | reporter.nih.gov |
| Pluripotent stem cell-based modeling of cigarette smoke injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $109,587 | April 1, 2020 | May 31, 2023 | ABO, KRISTINE | reporter.nih.gov |
| Early Changes of T2* Measures in Lung Tissues using deltaTE-UTE MRI on healthy and COPD Patients | NIH | National Heart, Lung, and Blood Institute | 2025 | $108,003 | August 15, 2025 | May 31, 2027 | MALIS, VADIM | reporter.nih.gov |
| Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $107,232 | January 1, 2024 | June 30, 2027 | MERRITT, CARLY | reporter.nih.gov |
| Mitochondrial regulation of macrophage activation in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $97,884 | September 30, 2022 | September 29, 2024 | SUI, JUSTIN | reporter.nih.gov |
| Air pollution, biomarkers of exposure, and lung function in vulnerable populations | NIH | National Institute of Environmental Health Sciences | 2024 | $86,004 | August 1, 2024 | ZETLEN, HILARY LAURA | reporter.nih.gov | |
| Cardiopulmonary Manifestations and Translational Potential of a Novel Radiographic Biomarker of Pulmonary Vascular Morphology | NIH | National Heart, Lung, and Blood Institute | 2021 | $85,554 | June 3, 2019 | June 2, 2022 | SYNN, ANDREW | reporter.nih.gov |
| Understanding the Genetic Contributions to Variation in Ozone Exposure Response | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $80,692 | September 1, 2024 | August 31, 2027 | LESTER, SARAH ANN | reporter.nih.gov |
| Phenotypes of Muscle Loss in Smokers | NIH | National Heart, Lung, and Blood Institute | 2022 | $79,168 | July 1, 2022 | June 30, 2023 | ZOU, RICHARD HANG | reporter.nih.gov |
| Assessing Racial Bias in Pulmonary Medicine from the Interpretation of Pulmonary Function Tests | NIH | National Heart, Lung, and Blood Institute | 2023 | $78,552 | July 1, 2023 | June 30, 2024 | BREMS, JOHN HENRY | reporter.nih.gov |
| Investigating the Resilient Smoker | NIH | National Heart, Lung, and Blood Institute | 2021 | $77,142 | August 1, 2019 | July 31, 2022 | OH, ANITA | reporter.nih.gov |
| Targeting the ACOD1 immunometabolic pathway of lung myeloid cells to reduce environmental exposure-induced lung disease | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $76,018 | January 15, 2024 | December 31, 2025 | SCHWAB, AARON | reporter.nih.gov |
| A Non-invasive, Wearable, Miniaturized Auscultation Device for Diagnosis of Pulmonary Diseases | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $75,502 | September 15, 2020 | June 30, 2023 | AYAZI, FARROKH | reporter.nih.gov |
| Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $75,477 | February 1, 2023 | May 31, 2024 | SMITH, ANNA R. | reporter.nih.gov |
| Identification of a Wnt/ Beta-catenin responsive adult lung epithelial progenitor cell for tissue repair in chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $75,130 | August 1, 2019 | July 31, 2022 | HU, YAN | reporter.nih.gov |
| Effect of chronic cigarette smoking on human microvascular endothelial cell metabolism and function | NIH | National Heart, Lung, and Blood Institute | 2021 | $74,886 | July 1, 2021 | June 30, 2022 | GOEL, KHUSHBOO | reporter.nih.gov |
| Allosteric Pharmacologic Chaperones for alpha-1 Antitrypsin Mutants | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $68,446 | February 1, 2022 | January 31, 2024 | GUERRERO, ADRIAN M. | reporter.nih.gov |
| Developing a novel adenine base editor tool for in vivo alpha-1 antitrypsin deficiency gene correction. | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $68,124 | September 1, 2024 | August 31, 2029 | GAO, JENNY | reporter.nih.gov |
| CT Characteristics of Emphysema for Evaluation of Pulmonary Nodules | NIH | National Heart, Lung, and Blood Institute | 2021 | $65,016 | August 1, 2021 | March 9, 2022 | KINSEY, CHARLES MATTHEW | reporter.nih.gov |
| Mechanisms and clinical relevance of hypercapnia-induced skeletal muscle atrophy in Chronic Obstructive Pulmonary Disease (COPD) | NIH | National Heart, Lung, and Blood Institute | 2021 | $61,776 | July 15, 2016 | March 9, 2022 | JAITOVICH, ADOLFO ARIEL | reporter.nih.gov |
| The Clinical Utility of Race-Specific Pulmonary Function in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $55,330 | December 1, 2021 | June 30, 2022 | BAUGH, AARON DORIAN | reporter.nih.gov |
| B cell-adaptive Immune Profile in Emphysema-predominant COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $49,060 | September 1, 2020 | April 15, 2022 | POLVERINO, FRANCESCA | reporter.nih.gov |
| Cholesterol Regulation of EGFR-dependent Vasoconstriction in Chronic Hypoxia-induced Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $49,025 | February 1, 2022 | May 12, 2023 | AHMADIAN, ROSSTIN | reporter.nih.gov |
| FASEB SRC: The Lung Epithelium Conference: In Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 | $40,000 | April 1, 2022 | March 31, 2023 | KROPSKI, JONATHAN ANDREW | reporter.nih.gov |
| Improving the Generalizability of Deep Neural Networks by Teaching them Lung Cancer Pathophysiology | NIH | National Cancer Institute | 2022 | $33,190 | August 1, 2022 | August 30, 2023 | MASQUELIN, AXEL HERVE PATRICK | reporter.nih.gov |
| The Effect of Phthalates on COPD Morbidity | NIH | National Heart, Lung, and Blood Institute | 2021 | $32,623 | August 7, 2020 | January 31, 2022 | BELZ, DANIEL CARPENTER | reporter.nih.gov |
| 2025 Elastin, Elastic Fibers and Microfibrils Gordon Research Conference and Gordon Research Seminar | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $25,000 | May 1, 2025 | April 30, 2026 | KOZEL, BETH A | reporter.nih.gov |
| Pulmonary Endothelial-Mesenchymal Crosstalk in Hyperactive mTOR Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 | $24,957 | January 1, 2022 | April 30, 2022 | LIN, SUSAN M | reporter.nih.gov |
| Bronchiolar Dysplasia in COPD is Governed by Loss of Polycomb Repressive Complex 2 | NIH | National Heart, Lung, and Blood Institute | 2021 | $23,605 | March 15, 2020 | October 14, 2021 | BYRD, ARIA | reporter.nih.gov |
| Characterization of Adenine Nucleotide Translocase (ANT) and Actin-Interacting Protein 1 (AIP1) as Protectors Against Cigarette Smoke | NIH | National Heart, Lung, and Blood Institute | 2021 | $20,515 | February 16, 2019 | July 2, 2021 | NGUYEN, JENNIFER | reporter.nih.gov |
| Genetic Epidemiology of GERD in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 | $18,742 | February 2, 2023 | August 11, 2023 | WILSON, AVA C | reporter.nih.gov |
| Leveraging prior knowledge to classify Indeterminate Lung Nodules in CT images using Deep Neural Networks | NIH | National Cancer Institute | 2022 | $18,155 | January 1, 2022 | July 31, 2022 | MASQUELIN, AXEL HERVE PATRICK | reporter.nih.gov |
| A multi-faceted intervention to promote adoption of clean fuel technologies for respiratory health in Peru | NIH | National Heart, Lung, and Blood Institute | 2021 | $12,101 | January 1, 2018 | March 28, 2021 | POLLARD, SUZANNE | reporter.nih.gov |
| 2025 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar | NIH | National Heart, Lung, and Blood Institute | 2025 | $10,000 | July 24, 2025 | June 30, 2026 | MAJKA, SUSAN M | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 214 | $527,341,518 | 0 | $0 |
| 2024 | 226 | $654,724,499 | 0 | $0 |
| 2023 | 214 | $949,697,038 | 0 | $0 |
| 2022 | 221 | $750,766,925 | 0 | $0 |
| 2021 | 224 | $787,258,553 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.